The Nutshell

» cell & molecular biology, cancer and policy

Daily News Roundup

Most Recent

image: Viral Protein Boosts Muscle Mass in Male Mice

Viral Protein Boosts Muscle Mass in Male Mice

By | September 14, 2016

An endogenous retrovirus that supports placenta formation in females also helps male mice build muscle, according to a study.

0 Comments

image: Novartis Drops Gene Therapy Research

Novartis Drops Gene Therapy Research

By | September 6, 2016

The company has shuttered its experimental cell and gene cancer therapy unit, firing more than 100 researchers.

1 Comment

image: Week in Review: August 29–September 2

Week in Review: August 29–September 2

By | September 2, 2016

Roger Tsien dies; the CRISPR patent dispute you’ve never heard of; immunotherapy for Alzheimer’s; Tasmanian devils developing resistance to transmissible cancer

0 Comments

image: Popular Tumor Cell Line Contaminated

Popular Tumor Cell Line Contaminated

By | August 31, 2016

A commercially available glioblastoma cell line appears to be from a different source than its stated origins.

0 Comments

image: Stem Cells Drive Cancer Risk in Mice

Stem Cells Drive Cancer Risk in Mice

By | August 26, 2016

Mutations that arise during stem cell division contribute to the development of cancers in a variety of organs, according to a study.

0 Comments

image: Seven More Retractions for Cancer Researcher

Seven More Retractions for Cancer Researcher

By | August 10, 2016

All of the papers had been published in the Journal of Biological Chemistry.

1 Comment

Science advocacy organizations have drafted a list of 20 questions for Hillary Clinton, Gary Johnson, Jill Stein, and Donald Trump; will post responses as they roll in.

0 Comments

image: Wolf Species Are Part Coyote

Wolf Species Are Part Coyote

By | July 28, 2016

Genomic analysis reveals wolves and coyotes have hybridized, potentially complicating wolves' protection under the US Endangered Species Act.

0 Comments

image: CRISPR Therapy to Enter Trials

CRISPR Therapy to Enter Trials

By | July 25, 2016

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

0 Comments

image: Distinguishing Circulating Tumor from Normal Cell-Free DNA

Distinguishing Circulating Tumor from Normal Cell-Free DNA

By | July 19, 2016

Fragments of circulating DNA from tumors are around 20 to 30 base pairs shorter than those from healthy cells, researchers report.

0 Comments

Popular Now

  1. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. What Sensory Receptors Do Outside of Sense Organs
RayBiotech